How many employees work at Rarity Bioscience?
Rarity Bioscience AB has approximately 37 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Rarity Bioscience’s total headcount has grown 185.9% from 13 employees in 2023 to 37 in 2026.
Is Rarity Bioscience hiring right now?
Yes, Rarity Bioscience is actively hiring. Rarity Bioscience had 2 active job postings in 2026, a 200.0% increase from 2025 — see job openings & hiring trends.
About Rarity Bioscience’s Workforce
Rarity Bioscience AB is a Biotech and Healthcare Services company that employs 37 people worldwide as of March 2026. It is the 4th-largest by headcount among its peers. Founded in 2021, the company is headquartered in Uppsala, Sweden.
Rarity Bioscience's workforce has grown 185.9% from 2023 to 2026, up 16.1% year over year in 2026. Its workforce is concentrated most in Northern Europe (97.0%), followed by North America (3.0%).
Rarity Bioscience's functional groups are Finance and Operations (46.5%), Engineering (35.5%), and Sales and Marketing (18.0%), with Finance and Operations growing fastest (up 27.6%). The average salary is $100,475, highest in Northern Europe at a median of $76,000, down 1.8% year over year in 2026.
Rarity Bioscience's active job postings rose 200.0% in 2026 to 2, with new postings per month climbing from 0 in 2023 to 1 in 2026.
Sourced from Revelio Labs workforce data.
- Headquarters
- Uppsala, Sweden
- Founded
- 2021
- Industry
- Biotech and Healthcare Services
- Employees
- 37
- YoY
- +16.1% (+12)
As of March 2026
Rarity Bioscience workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Rarity Bioscience. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsRarity Bioscience Annual Employee Count (2023-2026)
- Rarity Bioscience had 37 employees in 2026, a 16.1% increase (+12) from 2025.
- Rarity Bioscience had 37 employees in 2025, a 17.3% increase (+17) from 2024.
- Rarity Bioscience had 20 employees in 2024, a 16.8% increase (+6) from 2023.
- Rarity Bioscience had 14 employees in 2023, a 0% no change (+3) from 2022.
Rarity Bioscience's total workforce has grown from 13 employees in 2023 to 37 in 2026.
Rarity Bioscience AB quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 37 | +12 | +16.1% |
| 2025 | Q4 | 37 | +17 | +17.3% |
| 2025 | Q3 | 30 | +12 | +10.2% |
| 2025 | Q2 | 27 | +11 | +10.3% |
| 2025 | Q1 | 25 | +9 | +10.3% |
| 2024 | Q4 | 20 | +6 | +16.8% |
| 2024 | Q3 | 18 | +5 | +14.2% |
| 2024 | Q2 | 16 | +3 | +5.4% |
| 2024 | Q1 | 16 | +5 | +5.9% |
| 2023 | Q4 | 14 | +3 | +0.0% |
| 2023 | Q3 | 13 | +3 | +0.0% |
| 2023 | Q2 | 13 | +3 | +10.4% |
See Rarity Bioscience's complete headcount history, including quarterly breakdowns.
Get the DataRarity Bioscience Employee Count by Region (2026)
Northern Europe accounts for the largest share of Rarity Bioscience's global workforce with approximately 97% of total employees, followed by North America.
Rarity Bioscience employees by region
| Region | Employees | % of Total |
|---|---|---|
| Northern Europe | 36 | 97.0% |
| North America | 1 | 3.0% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataRarity Bioscience Employee Count by Department (2026)
Rarity Bioscience's employee groups are Finance and Operations (46.5%), Engineering (35.5%), and Sales and Marketing (18.0%).
Rarity Bioscience employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 17 | 46.5% |
| Engineering | 13 | 35.5% |
| Sales and Marketing | 7 | 18.0% |
Compare Rarity Bioscience's department mix to industry peers.
See Full DataRarity Bioscience Employee Salary by Region (2026)
Rarity Bioscience's average employee salary is $100,475 globally. Employees in Northern Europe receive the highest compensation.
Rarity Bioscience median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| Northern Europe | $76,000 |
Unlock salary by role, level, and city — and compare to Rarity Bioscience's industry peers.
Unlock Salary DataRarity Bioscience Job Openings and Hiring Trends (2023-2026)
- Rarity Bioscience had 2 active job postings in 2026, a 200.0% increase (+2) from 2025.
- Rarity Bioscience had 0 active job postings in 2025, a 0% no change from 2024.
- Rarity Bioscience had 0 active job postings in 2024, a 0% no change from 2023.
- Rarity Bioscience had 0 active job postings in 2023, a 200.0% decline from 2022.
- Hiring velocity in 2026: 1 new roles/month, up from 1 in 2025 and 1 in 2024.
Rarity Bioscience's hiring is accelerating: active job postings rose 200.0% in 2026 to 2, with new postings per month climbing from 0 in 2023 to 1 in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataSimilar Companies
Similar Biotech and Healthcare Services Companies by Employee Count
Frequently Asked Questions About Rarity Bioscience
- How fast is Rarity Bioscience growing?
- In 2026, Rarity Bioscience's headcount grew 16.1% to 37 employees, up from 25 in 2025.
- See the full headcount history
- Where are Rarity Bioscience employees located?
- Most Rarity Bioscience employees are based in Northern Europe (97.0% of headcount), followed by North America.
- Explore where the workforce is based
- What is the average salary at Rarity Bioscience?
- The average employee salary at Rarity Bioscience is approximately $100.5k per year.
- Analyze the salary distribution
- How many new job postings does Rarity Bioscience open per year?
- In Q1 2026, Rarity Bioscience opened 2 new job postings. In 2025, Rarity Bioscience opened 7 new job postings — about 1 per month.
- Track hiring trends by role
- When was Rarity Bioscience founded and where is it headquartered?
- Rarity Bioscience was founded in 2021 and is headquartered in Uppsala, Sweden.
- Compare Rarity Bioscience to industry peers
Speak with a workforce expert about Rarity Bioscience.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.